Schools of Nursing and Medicine, University of California, San Francisco, CA, USA.
J Clin Oncol. 2011 Mar 10;29(8):1001-6. doi: 10.1200/JCO.2010.30.9104. Epub 2011 Jan 31.
This study compared the occurrence rates for and severity ratings of sleep disturbance in patient-family caregiver (FC) dyads.
In total, 102 dyads were recruited from two radiation therapy (RT) departments. Patients and their FCs completed the Pittsburgh Sleep Quality Index (PSQI) and the General Sleep Disturbance Scale (GSDS) and wore wrist actigraphs to obtain subjective and objective measures of the occurrence and severity of sleep disturbance at the initiation of RT. Match paired t tests were used to evaluate for dyadic differences.
No differences were found in the occurrence of clinically significant levels of sleep disturbance between patients and their FCs that ranged between 40% and 50% using subjective and objective measures. Few differences were found in the severity of any of the sleep-wake parameters between patients and FCs using both the subjective and objective measures of sleep disturbance.
The findings from this study suggest that patients with cancer and their FCs experience similar levels of sleep disturbance and that both groups could benefit from interventions that aim to promote restful sleep. In addition to routine and systematic assessment of sleep disturbance by oncology clinicians, interventions are needed that take into account the specific needs of the patient and the FC as well as the potential for partners' sleep patterns to influence one another.
本研究比较了患者-家属照护者(FC)二人组中睡眠障碍的发生频率和严重程度评分。
共有 102 对二人组从两个放射治疗(RT)部门招募而来。患者及其 FC 完成了匹兹堡睡眠质量指数(PSQI)和一般睡眠障碍量表(GSDS),并佩戴腕部活动记录仪以获得 RT 开始时睡眠障碍发生和严重程度的主观和客观测量。使用配对 t 检验评估了二联体之间的差异。
使用主观和客观测量,在 40%至 50%的范围内,患者和 FC 之间并未发现临床显著水平的睡眠障碍发生存在差异。使用主观和客观睡眠障碍测量方法,在任何睡眠-觉醒参数的严重程度方面,患者和 FC 之间也几乎没有差异。
本研究的结果表明,癌症患者及其 FC 经历相似水平的睡眠障碍,两组都可能受益于旨在促进睡眠的干预措施。除了肿瘤学临床医生对睡眠障碍进行常规和系统评估外,还需要干预措施,这些措施需要考虑患者和 FC 的特定需求,以及伴侣的睡眠模式可能相互影响的潜力。